NCR3 Kit ELISA
-
- Antigène Voir toutes NCR3 Kits ELISA
- NCR3 (Natural Cytotoxicity Triggering Receptor 3 (NCR3))
-
Reactivité
- Humain
- Méthode de détection
- Colorimetric
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 15.625 pg/mL - 1000 pg/mL
- Seuil minimal de détection
- 15.625 pg/mL
- Application
- ELISA
- Fonction
- Human NKp30/NCR3 ELISA Kit is an ELISA Kit against NKp30/NCR3.
- Type d'échantillon
- Plasma, Serum, Tissue Homogenate
- Analytical Method
- Quantitative
- Sensibilité
- < 9.375 pg/mL
- Featured
- Discover our best selling NCR3 Kit ELISA
- Top Product
- Discover our top product NCR3 Kit ELISA
-
-
- Indications d'application
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Standard Form: Lyophilized
- Commentaires
-
The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Date de péremption
- 6 months
-
- Antigène Voir toutes NCR3 Kits ELISA
- NCR3 (Natural Cytotoxicity Triggering Receptor 3 (NCR3))
- Autre désignation
- NKp30/NCR3 (NCR3 Produits)
- Synonymes
- MGC133750 Kit ELISA, 1C7 Kit ELISA, CD337 Kit ELISA, LY117 Kit ELISA, MALS Kit ELISA, NKp30 Kit ELISA, Nkp30 Kit ELISA, natural cytotoxicity triggering receptor 3 Kit ELISA, NCR3 Kit ELISA, Ncr3 Kit ELISA
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-